Prostate Cancer 2020 Summit


The Prostate Cancer 2020 Summit was held online on Friday 4 December and Friday 11 December. Co-chaired by Professors Jeremy Millar and Damien Bolton, it included a policy context presentation and two consumer videos.

Part two of the data presentation begins 31:52.
Closed captions [CC] available. 

See the data presentation PDF here.
See the summary report and evaluation PDF here.

Policy context video (consumer videos below)
Closed captions [CC] available.

Consumer videos



Tue 17 November 2020

Co-designing a prostate cancer support portal

The BroSupPORTproject is 12 months into a 24-month cycle and was funded by the Victorian Agency for Health Information (VAHI). The Prostate Cancer Outcomes Registry-Victoria (PCOR-Vic), funded by Movember, was tasked with designing a portal that would help men living with prostate cancer. It aims to address how information and patient-reported outcome measures (PROMs) can be provided back to the patient. 

PCOR-Vic collects quality of life surveys from men with prostate cancer. At the end of the survey (once men have answered questions about their urinary-, bowel- and sexual function, and quality of life) patients are advised to contact their treating doctor, GP or the Cancer Council Information and Support line if they want further advice on managing their symptoms. They are thanked and informed that the information they provide will help other men in the future. Research staff at the Registry saw an opportunity to provide more assistance to these men – to enable them to be informed and to help them self-manage their symptoms through a reputable source.

The project was set up to understand the sort of information men want to receive, how they want to receive it and whether they would like to compare their quality of life results with other men who have been through a similar journey to them. The Registry surveys men 12 months after their treatment. If men haven't had treatment, they are surveyed 12 months from their diagnosis – the survey primarily targets survivorship. If a man is still experiencing problems 12 months later, it may be an indicator that something should be followed up or at a minimum, reviewed.

The portal acts as a one-stop shop to help men self-manage and understand their disease more. Called a portal and not a website, and developed in conjunction with Movember and VAHI, BroSupPORT will be accessed by men after they complete their PROMs through PCOR-Vic. The Registry is population-based and provides a systematic way to address challenges reported by patients in the survey. BroSupPORT will be piloted to understand whether it meets men’s needs by addressing information gaps. BroSupPORT will be assessed on the extent to which men like and find value in the information supplied through the portal. Eventually, it may be that men recently diagnosed with prostate cancer can also access the portal as a resource when they're making treatment decisions.

There are two phases to the BroSupPORT project. During the co-design phase, qualitative work was undertaken. Focus groups were held with clinicians and health professionals, and five two-hour long co-design workshops were held with men. One workshop was also offered to men and their partners. Some of the initial findings from these workshops are that men’s priorities shift over time. They have a diagnosis and treatment point, and then after-treatment and survivorship priorities. For the survivorship stage, the priority is helpful, practical and trusted advice on dealing with erectile dysfunction and incontinence.

The portal aims to not only provide information to address side effects apparent after treatment (such as incontinence, impotence and bowel problems) but also information on how to access assistance for a range of issues, including but not limited to topics such as poor mental health, obtaining sexual aids, obtaining financial assistance, and which health professional to see (the latter being unclear for patients). The portal also intends to provide information to alleviate patient anxiety around treatment and what to expect. While individual health services may have processes and resources for their patients, there’s no formal statewide mechanism for providing this sort of information to men with prostate cancer. The Registry has approximately 87% population coverage of men diagnosed with prostate cancer in Victoria. The portal will direct men to  already available quality resources where they exist.

During the co-design workshops, men unanimously declared that they want to be able to look at how their quality of life survey results compare with other men.  After men complete the survey, they will be able to compare their urinary, bowel and sexual function to other men in the Victorian population. This will be a consent-based, voluntary option. It will compare patients of similar age, stage of disease, and treatment type. It will allow men to see that they are comparing favorably to the population or other men like them, which can alleviate anxiety and normalise what they're going through. If a patient isn’t comparing favorably, it might catalyse change by prompting a patient to seek additional resources or a follow-up appointment. 



Prostate Cancer 2016 Summit update

December 2017

Under the 2018 Optimal Care Pathways Implementation Program Integrated Cancer Services will support local teams to identify opportunities for optimizing cancer care.

In its first phase the program will focus on investigating:

  • whether men with prostate cancer are routinely provided with an opportunity to explore all available management options?
  • is appropriate support accessible to meet men’s supportive care needs in the acute and survivorship phase following treatment?
  • rates of multidisciplinary meeting discussion of cases before starting treatment.
  • the extent to which Victorian GPs are aware and adhere to the NHMRC PSA testing and early management of test detected prostate cancer guidelines.

This will involve process mapping existing services and referral pathways both within hospitals and in the community and collecting data on patients’ experience of care.

The Prostate Cancer Outcomes Registry (PCOR) ANZ collects outcomes data for around 78 per cent of men diagnosed with prostate cancer in Victoria.

This data is useful in identifying the extent to which care aligns with some aspects of the prostate cancer optimal care pathway. Clinicians are encouraged to use PCOR data to inform their optimal care pathway service improvement.

For more information contact your local ICS


Watch the prostate cancer summit data presentation

About the Summit

Seventy-one delegates providing care or support to men with prostate cancer attended the summit on Friday 27th May to discuss and identify unwarranted variations in practice and cancer outcomes that could be addressed through state-wide action.

Professor Robert Thomas, Chief Advisor on Cancer (DHHS), opened the event and introduced the Prostate Cancer Optimal Care Pathway (OCP), highlighting the role of collaboration in addressing variations in cancer care for men with prostate cancer. Prof. Damien Bolton, Co-Chair of the Prostate Summit Working Party, set the scene and outlined the purpose of the day. A/Prof Jeremy Millar, Co-Chair of the Prostate Summit Working Party, presented available data on incidence, survival, disease characteristics and treatment planning of men with prostate cancer across Victoria.  View the prostate summit presentation.

A summary of variations in practice and outcomes for Victorian men with prostate cancer was available to participants as a reference.

Prostate cancer care in Victoria presentation highlights:

  • Age-standardised incidence of prostate cancer fell 39% from 2009-2014.  This is highly correlated with the decreasing number of PSA tests
  • Age-standardised mortality of prostate cancer increased from 1982-1994, then fell 2.5% per annum from 1994-2014
  • Lower age-standardised incidence in GRICS and WCMICS, and higher in NEMICS and SMICS.  This is partly explained by the higher incidences at higher Socio-economic Status (SES)
  • Men in regional areas are more likely to present with symptoms, have a TURP for diagnosis, and have metastatic and high-risk disease
  •  In regional areas men are less likely to be recorded as discussed in an MDM, and time from diagnosis to treatment is longer
  •  Prostatectomies are the most common treatment, performed in 42 hospitals, more commonly in metro and private facilities
  • Large variation in modalities of treatment across state even for similar risk disease
  •  Large variation in age-standardised mortality across regions associated with large variation in populations, disease presentation, access to care, and types of care available

Following the data presentation delegates engaged in small group discussions to identify state or local opportunities for action.

Prostate Summit Working Party
Prof Jeremy Millar Prof Damien Bolton    A/Prof Paul Mitchell
A/Prof Declan Murphy A/Prof Justin Tse Prof Ian Davis
A/Prof Sue Evans Dr Keen-Hun Tai Dr David Pook
Mr Mark Frydenberg Mr Paul Kearns Mr Rohan Hall
Mr Nathan Lawrentschuk Dr Mahesh Iddawela Mr Lachlan Dodds

Project team

Ms Mirela Matthews Ms Melinda Williams Mr Luc te Marvelde
Mr Don Vincendese Ms Ella Stuart Ms Megan Dendle


print text size increase